Deep-Dive Due Diligence AI Generated Report on Check-Cap Ltd. (CHEK)
Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.
These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.
25
$0.85
15
Speculative
Bearish
Lack of recent operational updates
C
biotech, speculative, short interest
Check-Cap: Recent Uptick Amidst Long-Term Declines
CHEK_OUT_1 [2025-04-28 06:47:48 -0400] 5982 Bytes | 1647 tokens | Cum: 1647 tkns (20.59% of 8k)
==========================================================================
We are in the 'Lightning Round' baby! It's 6:47 AM on Mon Apr 28, 2025, and I'm firing up the spotlight on Check-Cap (CHEK), moving from $0.6687 to $0.7601. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!
--- COMPANY PROFILE ---
Company: Check-Cap (CHEK)
IPO: 2015-03-18 (10 Years Ago)
Market Cap: $4,680,834
Shares Outstanding: 5,850,000
Exchange: XNAS
Description: Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
Here’s a list of headlines for Check-Cap:
May-31-24 01:53PM - CHEK Stock Earnings: Check-Cap Beats EPS for Q4 2023
Mar-26-24 08:35AM - Why Is Check-Cap (CHEK) Stock Up 44% Today?
Mar-25-24 07:37PM - Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement
Dec-22-23 10:36AM - SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD
Dec-14-23 07:13PM - Check-Cap Board of Directors Issues Letter to Shareholders
Dec-13-23 12:37PM - CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL
Dec-08-23 11:18AM - CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES
Dec-07-23 01:54PM - Leading Independent Proxy Advisory Firm ISS Recommends Check-Cap Shareholders Vote FOR the Keystone Dental Business Combination Agreement
Dec-05-23 03:42PM - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES
Nov-28-23 11:56AM - Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting
Nov-28-23 11:56AM 11:42AM - Keystone Dental Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Nov-27-23 08:00AM - Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Nov-13-23 04:05PM - Keystone Dental Announces Launch of the GENESIS ACTIVE Dental Implant System: Revolutionizing Dental Implantology
Nov-06-23 08:00AM - Keystone Dental Announces Market Launch of Nexus Connect, the First A.I. Enabled Intraoral Implant-Scan Analyzer for the Nexus iOS Full-Arch Solution
Oct-31-23 06:39PM - Notice of Extraordinary General Meeting of Shareholders
Oct-19-23 07:33PM - Check-Cap Issues Letter to Shareholders Regarding Proposed Merger with Keystone Dental Holdings
Oct-18-23 04:05PM - Keystone Dental Group Granted Patent from USPTO for Nexus IOS Solution
Sep-21-23 03:25PM - SYMETRYX OPPOSES CHEK CAP/KEYSTONE MERGER, WILL EVALUATE OPTIONS TO STOP TRANSACTION
Aug-16-23 05:08PM - Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive Business Combination Agreement
Aug-04-23 04:15PM - Check-Cap Reports Second Quarter 2023 Financial Results
Jul-25-23 10:22AM - SYMETRYX CORP INCREASES NON-BINDING OFFER TO ACQUIRE CHECK-CAP TO $4.60 PER SHARE
Jun-06-23 07:00AM - Check-Cap Announces Review of Strategic Alternatives and Reduction in Workforce
Prior AI Reports for CHEK:
1. 2025-03-20 – Score: 52 – Target: 1.0000 – Highs: 0.9300 / 0.9000 / 0.93
check-cap-ltd-shows-promising-upswing-amid-market-uncertainty
(Note: Highs = Same day / 2nd day / 3rd day)
Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.
B1 - 2024-03-26T17:45:27Z - Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B2 - 2024-03-26T12:00:29Z - Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
B3 - 2023-08-17T16:26:44Z - Why NICE Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
B4 - 2023-06-07T15:00:39Z - Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
B5 - 2023-05-12T17:09:06Z - Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
B6 - 2023-03-21T18:31:15Z - Nasdaq Up Over 100 Points; Crude Oil Rises 2%
==============
-> THE ROLE FOR AI:
==============
1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Check-Cap (CHEK).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.
2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.
3) You will request information by referencing documents by their code.
4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.
5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.
Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.
NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`
CHEK_IN_2 [2025-04-28 06:47:48 -0400] 3 Bytes | 2 tokens | Cum: 1649 tkns (20.61% of 8k)
==========================================================================
NEX
CHEK_OUT_3 [2025-04-28 06:47:49 -0400] 380 Bytes | 87 tokens | Cum: 1736 tkns (21.70% of 8k)
==========================================================================
We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.
Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.
CHEK_IN_4 [2025-04-28 06:47:49 -0400] 2 Bytes | 2 tokens | Cum: 1738 tkns (21.73% of 8k)
==========================================================================
A1
CHEK_OUT_5 [2025-04-28 06:47:50 -0400] 336 Bytes | 98 tokens | Cum: 1836 tkns (22.95% of 8k)
==========================================================================
Showing A1 (chunk 1 of 1): A1:
Document A1 not found. Only 0 articles available.
Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.
CHEK_IN_6 [2025-04-28 06:47:50 -0400] 3 Bytes | 2 tokens | Cum: 1838 tkns (22.98% of 8k)
==========================================================================
MOR
CHEK_OUT_7 [2025-04-28 06:47:51 -0400] 238 Bytes | 59 tokens | Cum: 1897 tkns (23.71% of 8k)
==========================================================================
This is our list of SEC filings.
If empty, the search returned no recent filings.
Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
CHEK_IN_8 [2025-04-28 06:47:51 -0400] 16 Bytes | 3 tokens | Cum: 1900 tkns (23.75% of 8k)
==========================================================================
Could you please
CHEK_OUT_9 [2025-04-28 06:47:51 -0400] 251 Bytes | 78 tokens | Cum: 1978 tkns (24.73% of 8k)
==========================================================================
You just read a chunk of S1.
You may now:
- Say "MOR" to continue this article
- Say "S2", "S3", etc. to request another
- Or say "NEX" to move to the next source
You are allowed up to 6 articles from this list. If you’re ready to move on, say NEX.
CHEK_IN_10 [2025-04-28 06:47:51 -0400] 13 Bytes | 3 tokens | Cum: 1981 tkns (24.76% of 8k)
==========================================================================
It seems like
CHEK_OUT_11 [2025-04-28 06:47:56 -0400] 4887 Bytes | 1166 tokens | Cum: 3147 tkns (39.34% of 8k)
==========================================================================
This is our set of metrics for Check-Cap.
Please analyze the numbers.
+---------------------+-----------------------+------------------------+----------------------+
| Volume: 421,130 | Perf Month: -7.45% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+---------------------+-----------------------+------------------------+----------------------+
| Avg Volume: 168.62K | Perf Quarter: -39.23% | Short Float: 1.27% | ROE: - |
+---------------------+-----------------------+------------------------+----------------------+
| Rel Volume: 2.56 | Index: - | Short Ratio: 0.33 | ROI: - |
+---------------------+-----------------------+------------------------+----------------------+
| RSI (14): 57.42 | Market Cap: 4.62M | Short Interest: 0.06M | Sales Surprise: - |
+---------------------+-----------------------+------------------------+----------------------+
| ATR (14): 0.08 | Shs Outstand: 5.85M | Beta: 0.23 | EPS Surprise: 46.99% |
+---------------------+-----------------------+------------------------+----------------------+
| SMA20: 12.14% | Shs Float: 4.38M | Sales Q/Q: - | P/E: - |
+---------------------+-----------------------+------------------------+----------------------+
| SMA50: 1.75% | Inst Own: 2.36% | Sales past 5Y: - | Earnings: - |
+---------------------+-----------------------+------------------------+----------------------+
| SMA200: -36.14% | Insider Own: 25.06% | Employees: - | |
+---------------------+-----------------------+------------------------+----------------------+
| Perf Week: 17.44% | Insider Trans: 0.00% | Debt/Eq: - | |
+---------------------+-----------------------+------------------------+----------------------+
The next section covers any insider trading by Check-Cap officers or majority shareholders (if available).
[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A
[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A
[Price Metrics - Last 30 Days]
Latest Close: 0.79
Average Volume: 39901.42
30-Day High: 0.81
30-Day Low: 0.6495
No detailed financial data available.
==== END OF FINANCIAL REPORT ====
You are now requested to write a summary analysis of Check-Cap (CHEK).
Please complete the report using the exact format:
FIELD[value]
1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Check-Cap.
2) MARKET_SCORE[]
This conversation was initiated because CHEK is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for CHEK.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.
3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, CHEK could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect CHEK to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]
4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.
5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.
6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)
7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.
8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.
9) SENTIMENT[]
bullish, bearish, neutral, or mixed
10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Check-Cap.
11) ETHICAL_RATING[]
Rate Check-Cap’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.
12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Check-Cap.
Provide any reasons you can use to support it.
Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.
Finally, thank you for participating!
CHEK_IN_12 [2025-04-28 06:47:56 -0400] 945 Bytes | 201 tokens | Cum: 3348 tkns (41.85% of 8k)
==========================================================================
BRIEF_SUMMARY[Check-Cap exhibits a volatile performance with significant declines over the past quarter and year, although recent weeks show an uptick. The company's low market cap and share price paired with minimal institutional ownership and a high insider ownership suggest a potentially speculative investment. The lack of sales and earnings data indicates limited operational activity or reporting.]
MARKET_SCORE[25]
PRICE_TARGET[0.85]
AI_RPT_HEADLINE[Check-Cap: Recent Uptick Amidst Long-Term Declines]
SQUEEZE_POTENTIAL[15]
TAGS[biotech, speculative, short interest]
STOCK_TYPE[speculative]
PRIMARY_CATALYST[lack of recent operational updates]
SENTIMENT[bearish]
IMPROVEMENT_SUGGESTION[Financial statements including revenue, net income, and detailed earnings reports would significantly improve analysis.]
ETHICAL_RATING[C]
UPCOMING_CATALYST[No immediate catalysts identified without further operational or financial updates]
CHEK_IN_13 [2025-04-28 06:47:56 -0400] 125 Bytes | 29 tokens | Cum: 3377 tkns (42.21% of 8k)
==========================================================================
====================================
[2025-04-28 06:47:56] # Analysis Completed
Elapsed Time: 9.08 seconds